Likevel vakte de humane resultatene stor oppmerksomhet (13, 14) og ledet senere til at disse medisinene ble utviklet og godkjent som behandling mot overvekt og fedme i Norge i hhv
Both target similar pathways (growth factor signaling, tissue repair), but BPC-157 is more targeted, lower cost, and produces a more consistent response based on this data
The rare individual who might consider this combination needs exceptional GI tolerance proven on prior GLP-1s, physician supervision with frequent monitoring, ability to afford $15,000-30,000 annually, understanding they're experimenting on themselves, and willingness to stop immediately if severe side effects emerge
Selik believes in an approach rooted in trust, communication, and measurable outcomes
In Ontario, Vitamin B12 injections are not covered by OHIP